• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

撤回：比索洛尔治疗心肌梗死伴心功能不全的疗效与安全性。

Retracted: The Efficacy and Safety of Bisoprolol in the Treatment of Myocardial Infarction with Cardiac Insufficiency.

作者信息

Methods In Medicine Computational And Mathematical

出版信息

Comput Math Methods Med. 2023 Jul 26;2023:9863585. doi: 10.1155/2023/9863585. eCollection 2023.

DOI:10.1155/2023/9863585
PMID:37538482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10396482/
Abstract

[This retracts the article DOI: 10.1155/2022/3098726.].

摘要

[本文撤回文章DOI: 10.1155/2022/3098726。]

相似文献

1
Retracted: The Efficacy and Safety of Bisoprolol in the Treatment of Myocardial Infarction with Cardiac Insufficiency.撤回：比索洛尔治疗心肌梗死伴心功能不全的疗效与安全性。
Comput Math Methods Med. 2023 Jul 26;2023:9863585. doi: 10.1155/2023/9863585. eCollection 2023.
2
Retracted: Effect of Enalapril Combined with Bisoprolol on Cardiac Function and Inflammatory Indexes in Patients with Acute Myocardial Infarction.撤回：依那普利联合比索洛尔对急性心肌梗死患者心功能及炎症指标的影响
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9818292. doi: 10.1155/2023/9818292. eCollection 2023.
3
The Efficacy and Safety of Bisoprolol in the Treatment of Myocardial Infarction with Cardiac Insufficiency.比索洛尔治疗心肌梗合并心力衰竭的疗效及安全性。
Comput Math Methods Med. 2022 Aug 25;2022:3098726. doi: 10.1155/2022/3098726. eCollection 2022.
4
Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery.比索洛尔可降低高危患者在成功进行大血管手术后长达两年内的心源性死亡和心肌梗死发生率。
Eur Heart J. 2001 Aug;22(15):1353-8. doi: 10.1053/euhj.2000.2555.
5
Retracted: Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction.撤稿：乌司他丁联合环磷腺苷葡胺治疗急性心肌梗死的临床疗效
Comput Math Methods Med. 2022 Nov 23;2022:9793601. doi: 10.1155/2022/9793601. eCollection 2022.
6
Retracted: Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate.撤稿：一名使用哌醋甲酯治疗的儿童在心肌梗死后发生心脏骤停。
Case Rep Pediatr. 2021 Jan 28;2021:4712417. doi: 10.1155/2021/4712417. eCollection 2021.
7
Study on the application effect of bisoprolol combined with sacubitril valsartan sodium tablets in the cardiac rehabilitation of patients with acute myocardial infarction combined with left heart failure after percutaneous coronary intervention (PCI).研究比索洛尔联合沙库巴曲缬沙坦钠片在经皮冠状动脉介入治疗（PCI）后合并急性心肌梗死和左心衰竭的患者心脏康复中的应用效果。
Ann Palliat Med. 2021 May;10(5):5455-5461. doi: 10.21037/apm-21-877. Epub 2021 May 19.
8
The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.比索洛尔对接受血管手术的高危患者围手术期死亡率和心肌梗死的影响。荷兰应用负荷超声心动图进行心脏风险评估的超声心动图研究组。
N Engl J Med. 1999 Dec 9;341(24):1789-94. doi: 10.1056/NEJM199912093412402.
9
Effects of Bisoprolol Transdermal Patches for Prevention of Perioperative Myocardial Injury in High-Risk Patients Undergoing Non-Cardiac Surgery　- Multicenter Randomized Controlled Study.比索洛尔透皮贴片预防高危非心脏手术患者围手术期心肌损伤的效果-多中心随机对照研究。
Circ J. 2020 Mar 25;84(4):642-649. doi: 10.1253/circj.CJ-19-0871. Epub 2020 Feb 21.
10
Retracted: Correlation between Glycated Haemoglobin Level, Cardiac Function, and Prognosis in Patients with Diabetes Mellitus Combined with Myocardial Infarction.撤回：糖尿病合并心肌梗死患者糖化血红蛋白水平、心功能与预后的相关性
Dis Markers. 2023 Jun 21;2023:9838245. doi: 10.1155/2023/9838245. eCollection 2023.

本文引用的文献

1
The Efficacy and Safety of Bisoprolol in the Treatment of Myocardial Infarction with Cardiac Insufficiency.比索洛尔治疗心肌梗合并心力衰竭的疗效及安全性。
Comput Math Methods Med. 2022 Aug 25;2022:3098726. doi: 10.1155/2022/3098726. eCollection 2022.